Original Research
Published on 14 Jan 2022
Fatal Pneumonia Associated With a Novel Genotype of Human Coronavirus OC43
in Virology
Frontiers in Microbiology
doi 10.3389/fmicb.2021.795449
- 9,341 views
- 18 citations
24 articles related to "Hcov Oc43"
Articles
Original Research
Published on 07 Jul 2022
Erythromycin Estolate Is a Potent Inhibitor Against HCoV-OC43 by Directly Inactivating the Virus Particle
in Clinical and Diagnostic Microbiology and Immunology
Frontiers in Cellular and Infection Microbiology
doi 10.3389/fcimb.2022.905248
- 5,701 views
- 16 citations
Original Research
Published on 10 Mar 2022
Targeting the Interaction Between Spike Protein and Nucleocapsid Protein for Suppression and Detection of Human Coronavirus OC43
in Viral Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2022.835333
- 4,528 views
- 10 citations
Original Research
Published on 17 May 2022
A Mouse-Adapted Model of HCoV-OC43 and Its Usage to the Evaluation of Antiviral Drugs
in Virology
Frontiers in Microbiology
doi 10.3389/fmicb.2022.845269
- 9,105 views
- 15 citations
Original Research
Published on 22 Jul 2025
Rapid generation of HCoV-229E and HCoV-OC43 reporter viruses and replicons for antiviral research
in Veterinary and Zoonotic Infection
Frontiers in Cellular and Infection Microbiology
doi 10.3389/fcimb.2025.1614369
- 3,721 views
Original Research
Published on 02 Nov 2022
Molecular evolution of human coronavirus-NL63, -229E, -HKU1 and -OC43 in hospitalized children in China
in Virology
Frontiers in Microbiology
doi 10.3389/fmicb.2022.1023847
- 9,938 views
- 30 citations
Original Research
Published on 01 Dec 2022
Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1029093
- 7,076 views
- 4 citations
Original Research
Published on 02 Sep 2022
Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination
in Clinical and Diagnostic Microbiology and Immunology
Frontiers in Cellular and Infection Microbiology
doi 10.3389/fcimb.2022.978440
- 5,474 views
- 23 citations
Original Research
Published on 06 Dec 2023
Antiviral functionalization of cellulose using tannic acid and tannin-rich extracts
in Virology
Frontiers in Microbiology
doi 10.3389/fmicb.2023.1287167
- 10,538 views
- 14 citations
Original Research
Published on 13 Aug 2021
Remdesivir and Cyclosporine Synergistically Inhibit the Human Coronaviruses OC43 and SARS-CoV-2
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2021.706901
- 7,309 views
- 23 citations
Original Research
Published on 10 Jul 2024
Repurposing the Open Global Health Library for the discovery of novel Mpro destabilizers with scope as broad-spectrum antivirals
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1390705
- 2,168 views
- 3 citations
Original Research
Published on 29 Aug 2023
The FDA-approved drug nitazoxanide is a potent inhibitor of human seasonal coronaviruses acting at postentry level: effect on the viral spike glycoprotein
in Virology
Frontiers in Microbiology
doi 10.3389/fmicb.2023.1206951
- 6,537 views
- 18 citations
Correction
Published on 19 Dec 2024
Corrigendum: Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1528449
- 2,184 views
Original Research
Published on 08 Sep 2022
Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination?
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2022.954093
- 3,864 views
- 15 citations
Original Research
Published on 10 Dec 2025
Modulation of viral replication, autophagy and apoptosis by induction and mutual regulation of transcription factors EB and E3 during coronavirus infection
in Virology
Frontiers in Microbiology
doi 10.3389/fmicb.2025.1609598
- 1,471 views
Original Research
Published on 27 Apr 2022
Atypical Antibody Dynamics During Human Coronavirus HKU1 Infections
in Virology
Frontiers in Microbiology
doi 10.3389/fmicb.2022.853410
- 8,173 views
- 13 citations